As of 2025-05-18, the Intrinsic Value of Hims & Hers Health Inc (HIMS) is 19.76 USD. This HIMS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 64.65 USD, the upside of Hims & Hers Health Inc is -69.40%.
The range of the Intrinsic Value is 13.30 - 44.20 USD
Based on its market price of 64.65 USD and our intrinsic valuation, Hims & Hers Health Inc (HIMS) is overvalued by 69.40%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 13.30 - 44.20 | 19.76 | -69.4% |
| DCF (Growth 10y) | 15.36 - 47.87 | 22.19 | -65.7% |
| DCF (EBITDA 5y) | 8.99 - 11.50 | 10.27 | -84.1% |
| DCF (EBITDA 10y) | 10.90 - 13.84 | 12.36 | -80.9% |
| Fair Value | 3.67 - 3.67 | 3.67 | -94.32% |
| P/E | 8.37 - 33.85 | 16.60 | -74.3% |
| EV/EBITDA | 5.81 - 9.70 | 7.27 | -88.8% |
| EPV | (0.04) - (0.27) | (0.16) | -100.2% |
| DDM - Stable | 7.60 - 28.35 | 17.98 | -72.2% |
| DDM - Multi | 6.36 - 18.68 | 9.51 | -85.3% |
| Market Cap (mil) | 14,460.27 |
| Beta | 3.17 |
| Outstanding shares (mil) | 223.67 |
| Enterprise Value (mil) | 14,186.53 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.55% |
| Cost of Debt | 5.00% |
| WACC | 6.69% |